03-05-2023 : 769 Pharmacists work as Medical Representative, of which 39 work as Senior Medical Representative * 02-06-2020 : 216 non Pharmacists work as Medical Representative, and 54 work as Senior Medical Representative * 05-06-2023 : In Lebanon, 88 generic medicinal products are more expensive than their Originators * 31-12-2019 : A medicinal product refused in Europe is marketed in Lebanon * 05-06-2023 : At least 332 medicinal products are available on the Lebanese market and are not available in the country of origin * 05-06-2023 : The price of the most expensive medicine available in Lebanon is 30434557 LL * 05-06-2023 : At least 1309 medicinal products are more expensive in Lebanon than in the countries of origin * 01-01-2019 : Daktavira, a generic of Daklinza, is registered in Lebanon but has no public price * 31-12-2019 : 352 medicinal products have been declared as non-marketed or withdrawn * 09-11-2021 : 64.72% of lebanese pharmacists are female * 31-12-2019 : 486 medicines were submitted to the Ministry of Health for a marketing authorization, and 514 medicines were registered to date * 15-06-2018 : The Minister of Public Health, has decided to suspend the commercialization of AB Slim (Ab Care Medical Herbs), which contains sibutramine, sildenafil and phenolphthalein * 01-06-2020 : Some Non-Marketed medicines are still imported * 01-06-2020 : Ixempra, a medicinal product withdrawn in Europe is imported to lebanon * 01-06-2020 : A vaccine made in India, removed from WHO list of prequalified vaccines, is submitted for registration in Lebanon * 01-06-2020 : Lebanon has 14 CROs, and is ranked as one of the largest countries in the world in clinical studies. According to the WHO, 817 clinical studies are currently conducted in Lebanon. * 05-01-2021 : * 01-10-2023 : Adakveo is now withdrawn from use in the European Union due to lack of therapeutic efficacy *
Accuzide* : | |
Type | Medicine Non Marketed |
Originator | B |
Agent | Droguerie Fattal |
Distributor | Droguerie Fattal |
Laboratory | Pfizer |
Responsible Party | Pfizer Pharma PFE GmbH |
Origin | Germany |
Manufacturer | Pfizer Manufacturing Deutschland GmbH |
Origin | Germany |
ATC | C09BA06 |
Revision Date | 01/03/2001 |
Accuzide* :
Accuzide* :
Accuzide* :
Accuzide* :
Accuzide* :
Hazard Level |
---|
◼ Major |
◼ Moderate |
◼ Minor |
◼ Safe |
Accuzide* :
Frequency | Percentage |
---|---|
Very Common | ≥ 1/10 |
Common | ≥ 1/100 - < 1/10 |
Uncommon | ≥ 1/1,000 - < 1/100 |
Rare | ≥ 1/10,000 - < 1/1,000 |
Very Rare | < 1/10,000 |
Unknown | Cannot be Estimated |
Effect | Frequency |
---|---|
Abdominal pain | Common |
Acute angle-closure glaucoma | Not known |
Agranulocytosis | Not known |
Alopecia | Uncommon |
Amblyopia | Uncommon |
Anaphylactoid reactions | Not known |
Angina pectoris | Common |
Angioedema (Angioneurotic oedema) (Quincke oedema) | Uncommon |
Antinuclear antibody (ANA) increased | Not known |
Arrhythmia | Not known |
Arthralgia (Pain joint) (Joint ache) | Uncommon |
Arthritis | Rare |
Asthenia | Common |
Back pain | Common |
Balance disorder | Rare |
Blood cholesterol increased | Not known |
Blood creatinine increased | Common |
Blood triglycerides increased | Not known |
Blood urea increased | Common |
Bronchitis | Common |
Bronchospasm | Not known |
Cephalea | Common |
Cerebrovascular accident | Not known |
Chest pain | Common |
Confusional state | Uncommon |
Constipation | Rare |
Cough | Common |
Depression | Uncommon |
Dermatitis exfoliative | Not known |
Dermatitis psoriasiform | Rare |
Diarrhoea (Diarrhea) | Common |
Dry mouth (Xerostomia) | Uncommon |
Dry throat | Uncommon |
Dysguesia (taste perversion) (Taste abnormality) (Taste disturbance) | Uncommon |
Dyspepsia | Common |
Dyspnoea (dyspnea) | Uncommon |
Eosinophilia | Not known |
Eosinophilic pneumonia | Rare |
Erectile dysfunction | Uncommon |
Erythema multiforme | Not known |
erythrocyte sedimentation rate (ESR) increased | Not known |
Fatigue | Common |
Flatulence | Uncommon |
Generalized oedema | Uncommon |
Glossitis | Rare |
Glucose tolerance decreased | Uncommon |
Gout | Common |
Haematocrit decreased | Not known |
Haemolytic anemia | Not known |
Hepatic enzyme increased | Not known |
Hepatitis | Not known |
Hyperhidrosis | Uncommon |
Hyperkalaemia | Common |
Hyperuricaemia | Common |
Hypotension | Uncommon |
Ileus | Very rare |
Insomnia | Common |
Jaundice cholestatic (Cholestatic icterus) | Not known |
Lightheadedness | Common |
Lyell Syndrome (Toxic epidermal necrolysis) | Not known |
Myalgia | Common |
Myocardial infarction | Uncommon |
Myopia | Not known |
Nausea | Common |
Nervousness | Uncommon |
Neutropenia | Not known |
Oedema peripheral | Uncommon |
Orthostatic hypotension | Not known |
Palpitations | Common |
Pancreatitis | Not known |
Paraesthesia (paresthesia) | Uncommon |
Pemphigus | Not known |
Pharyngitis | Common |
Photosensitivity reaction | Uncommon |
Proteinuria | Uncommon |
Pruritus | Uncommon |
Purpura | Not known |
Pyrexia | Uncommon |
Renal insufficiency | Uncommon |
Rhinitis | Common |
Serositis | Not known |
Serum bilirubin increased | Not known |
Sinusitis | Uncommon |
Skin Eruption | Uncommon |
Somnolence | Common |
Stevens-Johnson syndrome | Not known |
Syncope | Uncommon |
Systemic lupus erythematosus | Not known |
Tachycardia | Common |
Thrombocytopenia (Thrombopenia) | Not known |
Tinnitus | Uncommon |
Transient ischaemic attack | Uncommon |
Tubulointerstitial nephritis | Not known |
Upper respiratory tract infection | Common |
Urinary tract infection | Uncommon |
Urticaria | Very rare |
Vasculitis | Rare |
Vasodilation | Common |
Vertigo | Uncommon |
Viral infection | Uncommon |
Visual disturbance | Very rare |
Vomiting | Common |
Accuzide* :
NB : Products With Same Indication |
Different Units By MoH Code
Accuzide* MoH 8305 :
Form | Tablet, Film-Coated |
Package Size | Box of 30 |
Strength | 12.5/20mg |
Storage Condition | <25°C Protect from excessive heat and moisture |
NSSF | ✘ |
Quarantine | ✘ |
Reg. Number | 63315/1 |
Submission date | 01/01/2015 |
Registration Year | 2015 |
Archived Date | 02/03/2021 |
Price Comparison
● Country: | Abu Dhabi | |
● Package Size: | 30 | |
● Public Price: | 66 AED | ( 1,594,626.00 LBP ) |
● Pack size unit used: | 30 | |
● Cost/Unit: | 2,2 AED | ( 48,322.00 LBP ) |
● Pharmacy Price: | 53.39 AED | ( 1289955.79 LBP ) |
● Pricing Date: | 27/01/2021 | |
● Type: | Medicine Authorised |
● Country: | UAE | |
● Package Size: | 30's (10's Blister x 3) | |
● Public Price: | 66 AED | ( 1,594,626.00 LBP ) |
● Pack size unit used: | 30 | |
● Cost/Unit: | 2,2 AED | ( 48,322.00 LBP ) |
● Pharmacy Price: | 53.39 AED | ( 1289955.79 LBP ) |
● Pricing Date: | 21/08/2019 | |
● Type: | Medicine Authorised |
● Country: | Czech Republic | |
● Package Size: | 30 | |
● Public Price: | 188.54 CZK | ( 720,034.26 LBP ) |
● Pack size unit used: | 30 | |
● Cost/Unit: | 6,2847 CZK | ( 22,914.00 LBP ) |
● Reference: | SUKL | |
● Pricing Date: | 28/02/2020 | |
● Type: | Medicine Authorised |
● Country: | Sweden | |
● Package Size: | 100 | |
● Public Price: | 233.8 SEK | ( 1,965,790.40 LBP ) |
● Pack size unit used: | 100 | |
● Cost/Unit: | 2,338 SEK | ( 16,816.00 LBP ) |
● Pharmacy Price: | 185 SEK | ( 1555480 LBP ) |
● Pricing Date: | 23/04/2020 | |
● Type: | Medicine Authorised |
● Country: | Kuweit | |
● Package Size: | Boîte de 30 | |
● Public Price: | 5.5 KWD | ( 1,614,695.50 LBP ) |
● Pack size unit used: | 30 | |
● Cost/Unit: | 0,1833 KWD | ( 0.00 LBP ) |
● Type: | Medicine Non Marketed |
● Country: | Switzerland | |
● Package Size: | 30 | |
● Public Price: | 28.5 CHF | ( 2,947,470.00 LBP ) |
● Pack size unit used: | 30 | |
● Cost/Unit: | 0,95 CHF | ( 0.00 LBP ) |
● Exfactory Price: | 14.13 CHF | |
● Pricing Date: | 04/04/2021 | |
● Type: | Medicine Authorised |
● Country: | The Netherlands | |
● Package Size: | 30 | |
● Public Price: | 11.35 EUR | ( 1,099,542.60 LBP ) |
● Pack size unit used: | 30 | |
● Cost/Unit: | 0,3783 EUR | ( 0.00 LBP ) |
● Pharmacy Price: | 4.35 EUR | ( 421410.6 LBP ) |
● Reference: | Zorginstituut Nederland | |
● Pricing Date: | 15/06/2019 | |
● Type: | Medicine Non Marketed |
● Country: | France | |
● Package Size: | 28 | |
● Public Price: | 4.44 EUR | ( 430,129.44 LBP ) |
● Pack size unit used: | 28 | |
● Cost/Unit: | 0,1586 EUR | ( 0.00 LBP ) |
● Reference: | ansm | |
● Pricing Date: | 15/05/2021 | |
● Type: | Medicine Authorised |
● Country: | Turkey | |
● Package Size: | 30 | |
● Public Price: | 16.81 TRY | ( 45,050.80 LBP ) |
● Pack size unit used: | 30 | |
● Cost/Unit: | 0,5603 TRY | ( 0.00 LBP ) |
● Pricing Date: | 28/10/2020 | |
● Type: | Medicine Authorised |
● Country: | Germany | |
● Package Size: | 100 | |
● Public Price: | 30.73 EUR | ( 2,976,999.48 LBP ) |
● Pack size unit used: | 100 | |
● Cost/Unit: | 0,3073 EUR | ( 0.00 LBP ) |
● Pricing Date: | 15/05/2021 | |
● Type: | Medicine Authorised |
● Country: | Greece | |
● Package Size: | 28 | |
● Public Price: | 6.16 EUR | ( 596,756.16 LBP ) |
● Pack size unit used: | 28 | |
● Cost/Unit: | 0,22 EUR | ( 0.00 LBP ) |
● Exfactory Price: | 4.26 EUR | |
● Pharmacy Price: | 4.47 EUR | ( 433035.72 LBP ) |
● Reference: | National Organization for Medicines | |
● Pricing Date: | 25/02/2021 | |
● Type: | Medicine Authorised |
● Country: | Finland | |
● Package Size: | 100 | |
● Public Price: | 30.97 EUR | ( 3,000,249.72 LBP ) |
● Pack size unit used: | 100 | |
● Cost/Unit: | 0,3097 EUR | ( 0.00 LBP ) |
● Reference: | Kela | |
● Pricing Date: | 22/04/2021 | |
● Type: | Medicine Authorised |
● Country: | Jordan | |
● Package Size: | 30 | |
● Public Price: | 5.18 JOD | ( 648,644.78 LBP ) |
● Pack size unit used: | 30 | |
● Cost/Unit: | 0,1727 JOD | ( 0.00 LBP ) |
● Pharmacy Price: | 3.95 JOD | ( 494622.95 LBP ) |
● Reference: | JFDA | |
● Pricing Date: | 02/01/2021 | |
● Type: | Medicine Authorised |
● Country: | Italy | |
● Package Size: | 14UNITA | |
● Public Price: | 4.87 EUR | ( 471,786.12 LBP ) |
● Pack size unit used: | 14 | |
● Cost/Unit: | 0,3479 EUR | ( 0.00 LBP ) |
● Pricing Date: | 15/01/2021 | |
● Type: | Medicine Authorised |
● Country: | Ireland | |
● Package Size: | 28 | |
● Public Price: | 5.4 EUR | ( 523,130.40 LBP ) |
● Pack size unit used: | 28 | |
● Cost/Unit: | 0,1929 EUR | ( 0.00 LBP ) |
● Exfactory Price: | 7 EUR | |
● Pricing Date: | 09/10/2020 | |
● Type: | Medicine Authorised |
● Country: | Oman | |
● Package Size: | 30 | |
● Public Price: | 7.06 OMR | ( 1,628,982.04 LBP ) |
● Pack size unit used: | 30 | |
● Cost/Unit: | 0,2353 OMR | ( 0.00 LBP ) |
● Pricing Date: | 19/02/2021 | |
● Type: | Medicine Authorised |
● Country: | KSA | |
● Package Size: | 30 | |
● Public Price: | 23.3 SAR | ( 550,812.00 LBP ) |
● Pack size unit used: | 30 | |
● Cost/Unit: | 0,7767 SAR | ( 0.00 LBP ) |
● Reference: | sfda | |
● Pricing Date: | 16/01/2021 | |
● Type: | Medicine Authorised |
● Country: | Bahrain | |
● Package Size: | 30 | |
● Public Price: | 6.44 BHD | ( 1,531,006.96 LBP ) |
● Pack size unit used: | 30 | |
● Cost/Unit: | 0,2147 BHD | ( 0.00 LBP ) |
● Reference: | nhra | |
● Pricing Date: | 09/02/2021 | |
● Type: | Medicine Authorised |
● Country: | Belgium | |
● Package Size: | 28 | |
● Public Price: | 9.99 EUR | ( 967,791.24 LBP ) |
● Pack size unit used: | 28 | |
● Cost/Unit: | 0,3568 EUR | ( 0.00 LBP ) |
● Reference: | cbip | |
● Pricing Date: | 27/11/2020 | |
● Type: | Medicine Authorised |
● Country: | New Zealand |
● Package Size: | 30 tab |
● Exfactory Price: | 4.92 NZD |
● Reference: | New Zealand Pharmaceutical Management Agency |
● Pricing Date: | 01/04/2020 |
● Type: | Medicine Authorised |
Note
You have to register to view this info
Drop File